EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Self‐Assembled Skin Equivalents with Monoclonal CRISPR/Cas9‐Modified N/TERT‐1 Keratinocytes: A Cutting‐Edge Model for Human Skin and its Diseases

Marta Slaufova iD, Tugay Karakaya iD, Michela Di Filippo, Thomas Kündig, Hans-Dietmar Beer iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.71283 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Marta Slaufova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Hospital Zurich, Schlieren, Switzerland. Hauptthemen laut MEDLINE: Keratinocytes, CRISPR-Cas Systems, Skin, Skin Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vontobel Foundation, Wolfermann-Nägeli Foundation, Jubiläumsstiftung Swiss Life, Novartis Foundation for medical-biological Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human skin is a complex organ consisting of multiple cell types and serves as an essential barrier against environmental stressors. Due to ethical considerations and interspecies differences, in vitro human skin equivalents (SEs) are increasingly used to complement or replace animal models in mechanistic, pharmacological, and disease‐modeling studies. Scaffold‐free full‐thickness SEs, in which fibroblasts generate their own extracellular matrix, are particularly attractive because they provide high structural stability even during extended culture. However, the use of genetically defined keratinocyte populations in these SEs has remained limited. Here, scaffold‐free full‐thickness SEs incorporating wild‐type, polyclonal or monoclonal CRISPR/Cas9‐modified N/TERT‐1 keratinocytes, generated via electroporation, are established. Monoclonal N/TERT‐1 keratinocytes with targeted knockout (KO) of the crucial inflammasome component apoptosis‐associated speck‐like protein containing a caspase recruitment domain (ASC) form a differentiated epidermis but fail to secrete the proinflammatory cytokines interleukin (IL)‐1β and IL‐18 upon inflammasome activation, indicating complete functional ablation of inflammasome signaling in the 3D model. Moreover, SEs generated with gasdermin A (GSDMA)‐KO N/TERT‐1 keratinocytes illustrate the feasibility of analyzing genes induced during keratinocyte differentiation under physiological conditions. These results establish scaffold‐free full‐thickness SEs with monoclonal genetically modified N/TERT‐1 keratinocytes as a robust and reproducible human skin model for mechanistic studies and future disease‐modeling applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KeratinocytesCRISPR-Cas SystemsSkinSkin DiseasesHumansCell LineCARD Signaling Adaptor ProteinsInflammasomesInterleukin-1beta

Stichwörter der Autor:innen

N/TERT‐1 keratinocytescrispr/Cas9monoclonal knockoutscaffold‐freeskin equivalent

Substanzen

CARD Signaling Adaptor ProteinsInflammasomesInterleukin-1beta

Autor:innen und Institutionen

  • Department of Dermatology, University Hospital Zurich, Schlieren, Switzerland.
  • Faculty of Medicine, Department of Dermatology, University of Zurich, Zurich, Switzerland.

ORCID-Profile: Marta Slaufova, Tugay Karakaya, Hans-Dietmar Beer

Förderung

  • Vontobel Foundation
  • Wolfermann-Nägeli Foundation
  • Jubiläumsstiftung Swiss Life, Novartis Foundation for medical-biological Research
  • Monique Dornonville de la Cour Foundation
  • LEO Foundation
  • Swiss National Science Foundation
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Vontobel-Stiftung

Zitieren

APA

Slaufova, M., Karakaya, T., Di Filippo, M., Kündig, T., & Beer, H. D. (2026). Self‐Assembled Skin Equivalents with Monoclonal CRISPR/Cas9‐Modified N/TERT‐1 Keratinocytes: A Cutting‐Edge Model for Human Skin and its Diseases. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71283

Vancouver

Slaufova M, Karakaya T, Di Filippo M, Kündig T, Beer HD. Self‐Assembled Skin Equivalents with Monoclonal CRISPR/Cas9‐Modified N/TERT‐1 Keratinocytes: A Cutting‐Edge Model for Human Skin and its Diseases. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71283

BibTeX
@article{Slaufova2026,
  author = {Slaufova, Marta and Karakaya, Tugay and Di Filippo, Michela and Kündig, Thomas and Beer, Hans-Dietmar},
  title = {Self‐Assembled Skin Equivalents with Monoclonal CRISPR/Cas9‐Modified N/TERT‐1 Keratinocytes: A Cutting‐Edge Model for Human Skin and its Diseases},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.71283}
}
Kostenlos starten →